S100A4 and cancer: Calcimycin treatment also inhibited the formation of CRC metastasis in xenografted immunodeficient mice [102] Therefore, calcimycin-reduced S100A4 expression could be a functional strategy to restrict S100A4-induced cell migration and invasion in CRC cells and provide a potential therapeutic target against cancer metastasis [102].